Statistics for Arcturus Therapeutics Holdings (id:6503 ARCT)

Valuation metrics

Market cap

440.71M

Enterprise value

226.18M

Trailing P/E (ttm)

10.08

Forward P/E

-7.30

PEG ratio

-7.30

Price/Sales (ttm)

2.75

Price/Book (mrq)

1.68

Enterprise Value/Revenue

1.41

Enterprise Value/EBITDA

-2.94

Overview

Shares outstanding

27.09M

Float

24.80M

Shares short

4.58M

% Held by insiders

0.08%

% Held by institutions

0.90%

Average volume (10 days)

593.30K

Average volume (90 days)

Price summary

52-Week low

14.93

52-Week high

45.00

52-Week change

-41.40%

Beta

2.64

50-Day moving average

20.54

200-Day moving average

27.06

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

November 16th, 2017

Ex-dividend date

Last split factor

2:1

Last split date

November 16th, 2017

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-39.05%

Operating margin

-25.76%

Operational effectiveness

Return on assets

-12.15%

Return on equity

-23.12%

Income statement

Revenue (ttm)

5.96

Revenue per share (ttm)

5.96

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-77,007,000.00

Net income to common (ttm)

-62,643,000.00

Diluted EPS (ttm)

-2.33

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

237.18M

Total cash per share (mrq)

8.76

Total debt (mrq)

29.42M

Total Debt/Equity (mrq)

11.24

Current ratio (mrq)

476.30%

Book value per share (mrq)

9.67

Cash flow

Cash flow statement

-60,092,000.00

Levered free cash flow (LFCF)

-40,255,376.00